Hughes D C, Davis P L, Chen K W. "一种的合成方法" [P]. US Patent, US 9394472 B2, 2015-04-17.
Nowak P, Schröder R, Nielsen H. "Method for the Synthesis of 2-Oxiranemethanaminium, N,N-dimethyl-N-[2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethyl]-, chloride , polymer with methyl 2-propenoate" [P]. European Patent, EP 3723409 A1, 2021-07-19.
Park J H, O'Brien P Q, Lee S K. "A Process for Preparing High-Purity 2-Oxiranemethanaminium, N,N-dimethyl-N-[2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethyl]-, chloride , polymer with methyl 2-propenoate" [P]. US Patent, US 10291771 B2, 2019-01-11.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2018, 808, (1), 7628-7640.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2018, 1472, (8), 5350-5357.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of 2-Oxiranemethanaminium, N,N-dimethyl-N-[2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethyl]-, chloride , polymer with methyl 2-propenoate Using HRMS and NMR". J. Sep. Sci., 2018, 853, 1456-1469.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2016, 2463, 4120-4134.